These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32196922)

  • 1. Erythropoietin induces miRNA-210 by JAK2/STAT5 signaling in PBMCs of End-stage Renal Disease patients.
    Felaco P; Felaco M; Franceschelli S; Ferrone A; Gatta DMP; Speranza L; Patruno A; De Lutiis MA; Ballerini P; Sirolli V; Grilli A; Bonomini M; Pesce M
    FEBS J; 2020 Dec; 287(23):5167-5182. PubMed ID: 32196922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Erythropoietin-Stimulating Agent Responsiveness with Mortality in Hemodialysis and Peritoneal Dialysis Patients.
    Bae MN; Kim SH; Kim YO; Jin DC; Song HC; Choi EJ; Kim YL; Kim YS; Kang SW; Kim NH; Yang CW; Kim YK
    PLoS One; 2015; 10(11):e0143348. PubMed ID: 26588085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2008 Japanese Society for Dialysis Therapy: guidelines for renal anemia in chronic kidney disease.
    Tsubakihara Y; Nishi S; Akiba T; Hirakata H; Iseki K; Kubota M; Kuriyama S; Komatsu Y; Suzuki M; Nakai S; Hattori M; Babazono T; Hiramatsu M; Yamamoto H; Bessho M; Akizawa T
    Ther Apher Dial; 2010 Jun; 14(3):240-75. PubMed ID: 20609178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral zinc supplementation reduces the erythropoietin responsiveness index in patients on hemodialysis.
    Kobayashi H; Abe M; Okada K; Tei R; Maruyama N; Kikuchi F; Higuchi T; Soma M
    Nutrients; 2015 May; 7(5):3783-95. PubMed ID: 25988769
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kidney-secreted erythropoietin lowers lipidemia via activating JAK2-STAT5 signaling in adipose tissue.
    Li J; Yang M; Yu Z; Tian J; Du S; Ding H
    EBioMedicine; 2019 Dec; 50():317-328. PubMed ID: 31740386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamics of the erythropoiesis stimulating agent resistance index in incident hemodiafiltration and high-flux hemodialysis patients.
    Marcelli D; Bayh I; Merello JI; Ponce P; Heaton A; Kircelli F; Chazot C; Di Benedetto A; Marelli C; Ladanyi E; Kroczak M; Stuard S; Grassmann A; Scatizzi L; Brand K; Canaud B
    Kidney Int; 2016 Jul; 90(1):192-202. PubMed ID: 27178833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three Tyrosine Residues in the Erythropoietin Receptor Are Essential for Janus Kinase 2 V617F Mutant-induced Tumorigenesis.
    Ueda F; Tago K; Tamura H; Funakoshi-Tago M
    J Biol Chem; 2017 Feb; 292(5):1826-1846. PubMed ID: 27998978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoietin-mediated decrease of the redox-sensitive transcription factor NF-kappaB is inversely correlated with the hemoglobin level.
    Andrassy M; Bierhaus A; Hong M; Sis J; Schiekofer S; Humper PM; Chen J; Haap M; Renn W; Schleicher E; Häring HU; Andrassy K; Nawroth PP
    Clin Nephrol; 2002 Sep; 58(3):179-89. PubMed ID: 12357990
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin priming improves the vasculogenic potential of G-CSF mobilized human peripheral blood mononuclear cells.
    Kang J; Yun JY; Hur J; Kang JA; Choi JI; Ko SB; Lee J; Kim JY; Hwang IC; Park YB; Kim HS
    Cardiovasc Res; 2014 Oct; 104(1):171-82. PubMed ID: 25082847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammation, high ferritin, and erythropoietin resistance in indigenous maintenance hemodialysis patients from the Top End of Northern Australia.
    Majoni SW; Ellis JA; Hall H; Abeyaratne A; Lawton PD
    Hemodial Int; 2014 Oct; 18(4):740-50. PubMed ID: 24766376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging EPO and EPO receptor regulators and signal transducers.
    Kuhrt D; Wojchowski DM
    Blood; 2015 Jun; 125(23):3536-41. PubMed ID: 25887776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of plasma F2-isoprostanes and isofurans concentrations with erythropoiesis-stimulating agent resistance in maintenance hemodialysis patients.
    Rivara MB; Ikizler TA; Ellis CD; Mehrotra R; Himmelfarb J
    BMC Nephrol; 2015 Jun; 16():79. PubMed ID: 26045064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Skeletal muscle mass is associated with erythropoietin response in hemodialysis patients.
    Takata T; Mae Y; Yamada K; Taniguchi S; Hamada S; Yamamoto M; Iyama T; Isomoto H
    BMC Nephrol; 2021 Apr; 22(1):134. PubMed ID: 33863297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin induces sustained phosphorylation of STAT5 in primitive but not definitive erythrocytes generated from mouse embryonic stem cells.
    Tsuji-Takayama K; Otani T; Inoue T; Nakamura S; Motoda R; Kibata M; Orita K
    Exp Hematol; 2006 Oct; 34(10):1323-32. PubMed ID: 16982325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Co-stimulation with stem cell factor and erythropoietin enhances migration of c-Kit expressing cervical cancer cells through the sustained activation of ERK1/2.
    Aguilar C; Aguilar C; Lopez-Marure R; Jiménez-Sánchez A; Rocha-Zavaleta L
    Mol Med Rep; 2014 May; 9(5):1895-902. PubMed ID: 24626629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. JAK2/STAT5 signaling pathway mediates Bojungbangdocktang enhanced hematopoiesis.
    Lim J; Jeong SJ; Koh W; Han I; Lee HJ; Kwon TR; Jung JH; Kim JH; Lee HJ; Lee EO; Kim SH; Lee MH; Kim SH
    Phytother Res; 2011 Mar; 25(3):329-37. PubMed ID: 20669261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Essential role for Stat5 in the neurotrophic but not in the neuroprotective effect of erythropoietin.
    Byts N; Samoylenko A; Fasshauer T; Ivanisevic M; Hennighausen L; Ehrenreich H; Sirén AL
    Cell Death Differ; 2008 Apr; 15(4):783-92. PubMed ID: 18259195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors related to the absence of anemia in hemodialysis patients.
    Verdalles U; Abad S; Vega A; Ruiz Caro C; Ampuero J; Jofre R; Lopez-Gomez JM
    Blood Purif; 2011; 32(1):69-74. PubMed ID: 21346339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythropoietin-induced activation of the JAK2/STAT5, PI3K/Akt, and Ras/ERK pathways promotes malignant cell behavior in a modified breast cancer cell line.
    Shi Z; Hodges VM; Dunlop EA; Percy MJ; Maxwell AP; El-Tanani M; Lappin TR
    Mol Cancer Res; 2010 Apr; 8(4):615-26. PubMed ID: 20353997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.